Canada Clears First Generic Wegovy, Impacting Drug Prices

Canada has granted approval for the first generic version of the weight‑loss drug Wegovy, marking a significant step for pharmaceutical company Apotex. The decision follows two earlier milestones for the firm and could lower costs for patients worldwide. Analysts say the move may pressure pricing in other markets, including India, as demand for affordable obesity treatments rises.